We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.83%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$40.5B
AUM Growth
+$7.82B
(+24%)
Cap. Flow
+$9.9B
Cap. Flow
% of AUM
24.45%
Top 10 Holdings %
Top 10 Hldgs %
11.2%
Holding
4,410
New
905
Increased
1,516
Reduced
1,218
Closed
685
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$184M |
| 2 |
Dollar General
DG
|
+$152M |
| 3 |
MongoDB
MDB
|
+$129M |
| 4 |
Starbucks
SBUX
|
+$126M |
| 5 |
Costco
COST
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$111M |
| 2 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$97.7M |
| 3 |
Automatic Data Processing
ADP
|
+$90.7M |
| 4 |
Phillips 66
PSX
|
+$82.6M |
| 5 |
CVS Health
CVS
|
+$82.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 5.7% |
| 4 | Healthcare | 5.63% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Lineage Cell Therapeutics
LCTX
$257M
| $29.1K | ﹤0.01% |
24,631
-7,294
| -23% | -$9.92K |
|
|
TWOU
3677
DELISTED
2U Inc
TWOU
| $28.5K | ﹤0.01% |
384
-2,836
| -88% | -$290K |
|
|
ESPR
3678
DELISTED
Esperion Therapeutics
ESPR
| $27.4K | ﹤0.01% |
+27,969
| New | +$40.5K |
|
|
HLTH
3679
DELISTED
Cue Health Inc. Common Stock
HLTH
| $27.4K | ﹤0.01% |
61,916
-402,800
| -87% | -$184K |
|
|
LLAP
3680
DELISTED
Terran Orbital Corporation
LLAP
| $26.3K | ﹤0.01% |
+31,654
| New | +$41.9K |
|
|
GRRR
3681
Gorilla Technology Group
GRRR
$333M
| $25.7K | ﹤0.01% |
+2,958
| New | +$59.7K |
|
|
ONCY
3682
Oncolytics Biotech
ONCY
$96.9M
| $25.6K | ﹤0.01% |
+11,725
| New | +$28.6K |
|
|
LEV
3683
DELISTED
The Lion Electric Company
LEV
| $25K | ﹤0.01% |
+13,108
| New | +$28.5K |
|
|
HYPD
3684
Hyperion DeFi Inc
HYPD
$38M
| $23.7K | ﹤0.01% |
+179
| New | +$28.7K |
|
|
HYZN
3685
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $23.5K | ﹤0.01% |
+376
| New | +$25.4K |
|
3686
CuriosityStream
CURI
$139M
| $22.3K | ﹤0.01% |
31,495
+1,373
| +5% | +$1.2K |
|
3687
Smartbird Inc
BIRD
$21.7M
| $22.3K | ﹤0.01% |
1,003
-14,301
| -93% | -$385K |
|
|
LONA
3688
LeonaBio Inc
LONA
$69.4M
| $22.1K | ﹤0.01% |
1,094
-11
| -1% | -$282 |
|
3689
Kopin
KOPN
$663M
| $21.4K | ﹤0.01% |
+17,571
| New | +$28.5K |
|
3690
Hyperfine
HYPR
$94.7M
| $21K | ﹤0.01% |
+10,230
| New | +$23.6K |
|
3691
Knightscope
KSCP
$25M
| $20.9K | ﹤0.01% |
+526
| New | +$30.6K |
|
|
CRON
3692
Cronos Group
CRON
$1.05B
| $20.7K | ﹤0.01% |
10,373
-1,712
| -14% | -$3.35K |
|
|
TBHC
3693
DELISTED
The Brand House Collective
TBHC
| $20.3K | ﹤0.01% |
+11,794
| New | +$30.8K |
|
3694
ESS Tech
GWH
$22.1M
| $20.2K | ﹤0.01% |
+716
| New | +$17.4K |
|
3695
374Water
SCWO
$37.8M
| $19.9K | ﹤0.01% |
+1,607
| New | +$26.9K |
|
3696
INNOVATE Corp
VATE
$114M
| $19.6K | ﹤0.01% |
+1,211
| New | +$20.2K |
|
3697
Matinas BioPharma
MTNB
$1.55M
| $19.2K | ﹤0.01% |
+2,961
| New | +$36.4K |
|
|
GTHX
3698
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $18.5K | ﹤0.01% |
+12,815
| New | +$24.8K |
|
|
ISUN
3699
DELISTED
iSun, Inc. Common Stock
ISUN
| $18K | ﹤0.01% |
80,152
-44,824
| -36% | -$15.4K |
|
3700
Aveanna Healthcare
AVAH
$2.06B
| $17.6K | ﹤0.01% |
+14,819
| New | +$23K |
|
Similar funds
Squarepoint's Q3 2023 Portfolio in Review
As of Q3 2023, Squarepoint held 4,410 positions worth $40.5B, up 24% from $32.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $9.9B of net new capital in Q3 2023, opening 905 new positions and adding to 1,516 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Adobe, an estimated $111M trimmed.
- Squarepoint's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
- Squarepoint added most to Tesla in Q3 2023, an estimated $184M increase.
- Squarepoint's biggest Q3 2023 reduction was Adobe, cutting an estimated $111M.
- Squarepoint fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2023, selling an estimated $56.4M.
- Squarepoint's ten largest holdings make up 11% of its $40.5B portfolio in Q3 2023.
- Squarepoint opened 905 new positions and closed 685 in Q3 2023.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $40.5B.
Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.